GRPS (Gold River Productions) Notes Receivable: $0.0 Mil (As of Mar. 2096)


What is Gold River Productions Notes Receivable?

Gold River Productions GRPS Notes Receivable is $0.0 Mil as of Mar. 2096.

Gold River Productions's Notes Receivable for the quarter that ended in Mar. 2096 was $0.0 Mil.

Gold River Productions Notes Receivable Related Terms

Gold River Productions Notes Receivable Historical Data

* Premium members only.

The historical data trend for Gold River Productions's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gold River Productions Notes Receivable Chart

Gold River Productions Annual Data
Trend Mar92 Mar93 Mar94 Mar95
Notes Receivable
0.00 0.00 0.00 0.00

Gold River Productions Semi-Annual Data
Mar92 Mar93 Mar94 Mar95 Mar96
Notes Receivable 0.00 0.00 0.00 0.00 0.00

Gold River Productions Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.0 Mil mean?
Gold River Productions (GRPS) has a Notes Receivable of $0.0 Mil as of Mar. 2096. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Gold River Productions and its competitors.
Is Gold River Productions' Notes Receivable too high?
Gold River Productions' current Notes Receivable is $0.0 Mil.
How does Gold River Productions' Notes Receivable compare to KOAN and OWPC?
Gold River Productions' Notes Receivable of $0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Gold River Productions and its competitors. Gold River Productions's current Notes Receivable is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gold River Productions stock overvalued right now?
Gold River Productions (GRPS) has a current Notes Receivable of $0.0 Mil. The current Notes Receivable is $0.0 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Gold River Productions (GRPS), the current Notes Receivable is $0.0 Mil as of Mar. 2096. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gold River Productions Business Description

Address 1022 Shadyside Lane, Dallas, TX, USA, 75223
Gold River Productions Inc is a medical cannabinoids company involved in developing products targeting disease states as supplements. The company offers various products, including Wrinkle Cream, EnergyPlex CBD, Hemorrhoid Plus CBD, Addiction Kit, and Sominoplex-CBD, among others.